AAN Foundation launches new PSA on finding cure for brain disease

With one in six people in the United States now affected by brain disease such as dementia, multiple sclerosis and epilepsy, the American Academy of Neurology Foundation is marking its 20th anniversary with the launch of a new public service announcement (PSA) to raise awareness about the need for more research to cure brain disease.

"There is vast research potential for finding new treatments for brain disease, but limited funding to support it," said John Mazziotta, MD, PhD, Chair of the American Academy of Neurology Foundation's Board of Trustees and Professor and Chair of UCLA's Brain Mapping Center in Los Angeles. "It is essential that people join us now in our fight to find a cure for brain disease by supporting the Foundation."

The American Academy of Neurology Foundation has raised more than $16 million dollars for research into finding cures for brain disease, including stroke, which is the third leading cause of death in the United States, and Alzheimer's disease, which is the sixth leading cause of death in the nation.

"Brain disease is in the news every day, and it is nearly impossible to find someone who has not had a family member or friend affected by one of the many forms of brain disease that attack the brain and nervous system," said Mazziotta, who is also a Fellow of the American Academy of Neurology. "People are also concerned they, or their family members, will become affected by brain disease directly."

Source: American Academy of Neurology Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study unveils why glioblastoma becomes resistant to treatment